Description

CJC 1295 without DAC is a growth hormone releasing hormone analogue researched across endocrine and performance related studies. Its research profile allows investigation into GHRH signalling and pathways associated with growth hormone activity and IGF 1 regulation. Researchers study how this peptide interacts with endocrine mechanisms under controlled experimental conditions, contributing to broader research into hormonal signalling and biological performance pathways. The absence of DAC provides a distinct formulation for comparative research alongside other CJC 1295 variants. This product contains 10mg across 10 vials and is supplied for controlled laboratory research into growth hormone signalling, endocrine pathways, IGF 1 activity, and related biological mechanisms.